Drugs / VXA-G1.1-NN Oral Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03125473 | Apr → Jul 2017 | norovirus infectious disease | Vaxart | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VXA-G1.1-NN Oral Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03125473 ↗ |
| Modality | Vaccine | “adenoviral-vector based norovirus vaccine” NCT03125473 ↗ |
| Route | Oral | “administered orally” NCT03125473 ↗ |